Underrepresentation of female subjects in BE study to register Generic [Regulatives / Guidelines]

posted by Ohlbe – France, 2020-03-11 16:07 (1365 d 16:07 ago) – Posting: # 21251
Views: 4,327

Dear SKM,

❝ We have done a pilot study with 12 subjects (8 male and 4 female) and the results didn't meet the bioequivalence criteria.


So what ? It is a pilot. Was it powered to demonstrate BE ?

❝ However, when we exclude the female data it marginally meets the bioequivalency criteria of 80%-125%.


Did you pre-plan this male-only analysis in your protocol or statistical analysis plan ?

❝ Can we conduct the pivotal study only in Males?


Where do you intend to submit your data ? USA: the FDA wants males and females. Europe: EMA accepts studies in males only, but "we fear that we may fail if we include females" will not be an acceptable rationale.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,818 posts in 4,784 threads, 1,634 registered users;
31 visitors (0 registered, 31 guests [including 11 identified bots]).
Forum time: 08:15 CET (Europe/Vienna)

The greatest obstacle to discovery is not ignorance 
it is the illusion of knowledge.    Daniel J. Boorstin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5